WAILEA, Hawaii — In this video from Hawaiian Eye 2021, Todd Bazemore, chief operating officer at Kala Pharmaceuticals, offers a company update, including the recent approval of Eysuvis (loteprednol) for dry eye disease signs and symptoms.
Uncategorized
VIDEO: Eysuvis positioned as short-term solution for dry eye flares